Cas 397844-81-4,4-{3-[3-(2,6-Difluoro-phenyl)-pyrazol-5-yl]-thioureido}-benzenesulfonamide

397844-81-4

Post Buying Request

Basic information

Product Name: 4-{3-[3-(2,6-Difluoro-phenyl)-pyrazol-5-yl]-thioureido}-benzenesulfonamide
Synonyms:
CAS NO:397844-81-4
Molecular Formula:
Molecular Weight: 409.44
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-{3-[3-(2,6-Difluoro-phenyl)-pyrazol-5-yl]-thioureido}-benzenesulfonamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-{3-[3-(2,6-Difluoro-phenyl)-pyrazol-5-yl]-thioureido}-benzenesulfonamide(397844-81-4)
EPA Substance Registry System: 4-{3-[3-(2,6-Difluoro-phenyl)-pyrazol-5-yl]-thioureido}-benzenesulfonamide(397844-81-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 397844-81-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

397844-81-4 Suppliers

Recommended suppliers

397844-81-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 397844-81-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,7,8,4 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 397844-81:
(8*3)+(7*9)+(6*7)+(5*8)+(4*4)+(3*4)+(2*8)+(1*1)=214
214 % 10 = 4
So 397844-81-4 is a valid CAS Registry Number.

397844-81-4Upstream product

397844-81-4Downstream Products

397844-81-4Relevant academic research and scientific papers

Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases

-

, (2008/06/13)

Pyrazole-thiazole compounds that modulate and/or inhibit the activity of cyclin-dependent kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating cyclin-dependent diseases to modulate and/or inhibit

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 397844-81-4